Anders Bach

Anders Bach

Professor

ORCID: 0000-0003-4305-9910

Publication year:
All
1 - 10 out of 68Page size: 10
Sort by: 1st author
  1. Published

    Effects of the dimeric PSD-95 inhibitor UCCB01-144 in mouse models of pain, cognition and motor function

    Andreasen T., Jesper, Nasser, A., Caballero-Puntiverio, M., Sahlholt, M., Bach, Anders, Gynther, M., Strømgaard, Kristian & Pickering, Darryl S, 5 Jun 2016, In: European Journal of Pharmacology. 780, p. 166-73 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: Comparison with the NMDA receptor antagonist MK-801

    Andreasen T., Jesper, Bach, Anders, Gynther, M., Nasser, A., Mogensen, J., Strømgaard, Kristian & Pickering, Darryl S, Apr 2013, In: Neuropharmacology. 67, p. 193-200 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Design and synthesis of highly potent and plasma-stable dimeric inhibitors of the PSD-95-NMDA receptor interaction

    Bach, Anders, Chi, C. N., Pang, G. F., Olsen, L., Kristensen, Anders Skov, Jemth, P. & Strømgaard, Kristian, 2009, In: Angewandte Chemie - International Edition. 48, 51, p. 9685-9689

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Targeting protein-protein interactions: inhibitors of c-Myc/Max and PDZ domain proteins

    Bach, Anders, 2009, København: Det Farmaceutiske Fakultet. 196 p.

    Research output: Book/Report › Ph.D. thesis › Research

  5. Published

    Benzoxazolone derivatives as Acid Ceramidase inhibitors, and their use as medicaments

    Piomelli, D; Pagliuca, C.; Pizzirani, D.; Bach, A.; Realini, N.; De Vivo, M, P. D. P. C. ;. P. D. ;. B. A. ;. R. N. ;. D. V. M., 19 Nov 2015, Patent No. WO2015/173168A1, Priority date 12 May 2014, Priority No. IT/MI2014/A000863

    Research output: Patent

  6. Published

    Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor

    Bach, Anders, Clausen, B. H., Kristensen, L. K., Andersen, M. G., Ellman, D. G., Hansen, P. B. L., Hasseldam, Henrik, Heitz, M., Özcelik, D., Tuck, E. J., Kopanitsa, M. V., Grant, S. G. N., Lykke-Hartmann, K., Johansen, F. F., Lambertsen, K. L. & Strømgaard, Kristian, May 2019, In: Neuropharmacology. 150, p. 100-111 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Submitted

    High-affinity, dimeric inhibitors of PSD-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain

    Bach, Anders & Strømgaard, Kristian, 2012, (Submitted) Patent No. WO2012/156308 (Granted: EP2707014B1; US9139615B2)

    Research output: Patent

  8. Published

    Modified peptides as potent inhibitors of the PSD-95/NMDA receptor interaction

    Bach, Anders & Strømgaard, Kristian, 14 Jan 2010, Patent No. WO2010/004003 (Granted: EP2320927B1; US9241967B2)

    Research output: Patent

  9. Published

    Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1

    Bach, Anders, Stuhr-Hansen, N., Thorsen, T. S., Bork, N., Moreira, I. S., Frydenvang, Karla Andrea, Padrah, S., Christensen, Søren Brøgger, Madsen, Kenneth Lindegaard, Weinstein, H., Gether, Ulrik & Strømgaard, Kristian, 2010, In: Organic & Biomolecular Chemistry. 8, 19, p. 4281-4288 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Protein-protein interaktion: et nyt mål for udvikling af lægemidler

    Bach, Anders, Gottschalk, M., Kristensen, Anders Skov & Strømgaard, Kristian, 2008, In: Lægemiddelforskning. p. 10-12

    Research output: Contribution to journal › Journal article › Communication

Previous 1 2 3 4 5 6 7 Next

ID: 1304261